Sei Investments Co. lowered its position in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 2.5% in the 4th quarter, Holdings Channel.com reports. The fund owned 368,281 shares of the company’s stock after selling 9,463 shares during the period. Sei Investments Co.’s holdings in Perrigo were worth $9,469,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of PRGO. Quantbot Technologies LP boosted its stake in Perrigo by 1,879.3% during the fourth quarter. Quantbot Technologies LP now owns 13,796 shares of the company’s stock valued at $355,000 after buying an additional 13,099 shares during the period. Teacher Retirement System of Texas grew its holdings in shares of Perrigo by 18.2% during the fourth quarter. Teacher Retirement System of Texas now owns 40,411 shares of the company’s stock worth $1,039,000 after purchasing an additional 6,220 shares in the last quarter. West Tower Group LLC raised its stake in Perrigo by 16.6% in the fourth quarter. West Tower Group LLC now owns 118,914 shares of the company’s stock valued at $3,057,000 after purchasing an additional 16,922 shares in the last quarter. Xponance Inc. lifted its position in Perrigo by 11.7% during the fourth quarter. Xponance Inc. now owns 24,883 shares of the company’s stock valued at $640,000 after purchasing an additional 2,599 shares during the last quarter. Finally, First Eagle Investment Management LLC purchased a new position in Perrigo in the 4th quarter worth approximately $1,466,000. Institutional investors own 95.91% of the company’s stock.
Perrigo Price Performance
PRGO stock opened at $28.06 on Monday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The firm has a market cap of $3.83 billion, a P/E ratio of -23.98 and a beta of 0.48. The firm’s fifty day moving average is $26.11 and its 200 day moving average is $26.15. Perrigo Company plc has a 52 week low of $23.14 and a 52 week high of $33.46.
Perrigo Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were paid a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.13%. The ex-dividend date of this dividend was Friday, March 7th. This is a positive change from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s dividend payout ratio is -92.80%.
Wall Street Analyst Weigh In
PRGO has been the subject of a number of research analyst reports. Piper Sandler downgraded shares of Perrigo from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $34.00 to $27.00 in a report on Monday, January 6th. StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Finally, Argus cut Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $33.00.
Check Out Our Latest Report on PRGO
Insider Transactions at Perrigo
In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the sale, the executive vice president now owns 33,666 shares of the company’s stock, valued at $923,795.04. This represents a 18.81 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.70% of the company’s stock.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Further Reading
- Five stocks we like better than Perrigo
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- What is the Dow Jones Industrial Average (DJIA)?
- MarketBeat Week in Review – 03/24 – 03/28
- The 3 Best Blue-Chip Stocks to Buy Now
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.